Member of the editorial board of the journal «Veterinaria i kormlenie» Luis Enjuanes, director of the coronavirus group at the CNB-CSIC has been elected as new international member of the National Academy of Sciences of the United States. Enjuanes is currently leading one of the two CNB-CSIC projects to develop a vaccine against the SARS-CoV2 coronavirus. This election recognizes his distinguished and continuing achievements in original research. Enjuanes, CSIC research professor at the National Center for Biotechnology and director of the coronavirus group, has been working for more than 35 years on the mechanisms of replication, transcription, virulence and virus-host interaction of coronaviruses. Since January 2020, his group has been working on a vaccine against SARS-CoV-2, applying the scientific knowledge that they already used in previous coronavirus outbreks: 2002 SARS-COV and MERS in 2012.
Photo from the archive of the journal «Veterinaria i kormlenie»
Recognition of distinguished achievements
- By joint efforts – to ensure the epizootic blogging of the country
- Pig farming 2021: adapting to new realities